PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

HL HL4656

Orphan Drugs

answeredUnited Kingdom· UK Parliament· EN

Introduced

3 February 2025

Last action

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

12 February 2025

Summary

To ask His Majesty's Government what assessment they have made of the impact of the “cliff edge” in incremental cost-effectiveness ratios on orphan medicines that narrowly miss the criteria to be appraised by the National Institute for Health and Care Exc

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.